OPDUALAG (nivolumab and relatlimab-rmbw) injection

FDA approved Anti-Cancer medicine OPDUALAG (nivolumab and relatlimab-rmbw) injection is available upon request. Get best retail price of OPDUALAG (nivolumab and relatlimab-rmbw) injection from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected]. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Doctor.
Category: .

OPDUALAG (nivolumab and relatlimab-rmbw) injection

INDICATIONS AND USAGE
Opdualag is a premixed combination of nivolumab and relatlimab that is prepared and given through intravenous (IV) infusions. Opdualag is a prescription medicine used to treat adults who have a type of skin cancer called melanoma that has spread or cannot be removed by surgery (advanced melanoma) and children who are 12 years of age and older, who have melanoma that has spread or cannot be removed by surgery (advanced melanoma).
Opdualag was approved by the FDA in March 2022 and by the EMA in September 2022.
DOSAGE FORMS & STRENGTHS: Injection: 240 mg of nivolumab and 80 mg of relatlimab per 20 mL (12 mg and 4 mg per mL) in a single-dose vial.
Manufactured By: Bristol-Myers Squibb
Prescribing Information URL: Click Here

How To Make An Enquiry For OPDUALAG (nivolumab and relatlimab-rmbw) injection?

OPDUALAG (nivolumab and relatlimab-rmbw) injection, FDA approved Anti-Cancer medicine is available upon request. Get best retail price of OPDUALAG (nivolumab and relatlimab-rmbw) injection from trusted pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected]. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with doctor.

Nivolumab/relatlimab, is a fixed-dose combination medication use to treat melanoma. It contains nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody.[3] It is given by intravenous infusion. The combination was approved for medical use in the United States in March 2022, and in the European Union in September 2022. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.
The combination is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in people aged twelve years of age and older.

How And Where To Buy nivolumab and relatlimab-rmbw injection?

nivolumab and relatlimab-rmbw injection can be ordered on request direct from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery. To get best retail price/cost of nivolumab and relatlimab-rmbw injection in India, Call 8750295029 or Email [email protected]. FDA approved drugs of Australia, Canada, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    Get Access to REZUROCK (belumosudil) tablets In India

    Medvitaz Pharma is a Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer of Anti-Cancer Medicines / Drugs, used in chronic GVHD) treatment from India. Submit the request form for cost price of Brand Name “REZUROCK (belumosudil) tablets” or Generic Name “belumosudil tablets” can be imported for personal use under “patient name basis” treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Once we review your request and delivery process, we’ll send you an estimated price for the medicine within 1-2 days.